158 related articles for article (PubMed ID: 10706954)
41. Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.
Jonas S; John M; Boese-Landgraf J; Häring R; Prevost G; Thomas F; Rosewicz S; Riecken EO; Wiedenmann B; Neuhaus P
Langenbecks Arch Chir; 1995; 380(2):90-5. PubMed ID: 7760656
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical detection of somatostatin receptors in human ovarian tumors.
Schulz S; Schmitt J; Quednow C; Roessner A; Weise W
Gynecol Oncol; 2002 Feb; 84(2):235-40. PubMed ID: 11812080
[TBL] [Abstract][Full Text] [Related]
43. Somatostatin in neuroblastoma and ganglioneuroma.
Kogner P; Borgström P; Bjellerup P; Schilling FH; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
Eur J Cancer; 1997 Oct; 33(12):2084-9. PubMed ID: 9516858
[TBL] [Abstract][Full Text] [Related]
44. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
45. Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4.
Lupp A; Hunder A; Petrich A; Nagel F; Doll C; Schulz S
Neuroendocrinology; 2011; 94(3):255-64. PubMed ID: 21952553
[TBL] [Abstract][Full Text] [Related]
46. Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology in the retina.
Mastrodimou N; Vasilaki A; Papadioti A; Low MJ; Hoyer D; Thermos K
Neuropeptides; 2006 Oct; 40(5):365-73. PubMed ID: 17010429
[TBL] [Abstract][Full Text] [Related]
47. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20.
Demchyshyn LL; Srikant CB; Sunahara RK; Kent G; Seeman P; Van Tol HH; Panetta R; Patel YC; Niznik HB
Mol Pharmacol; 1993 Jun; 43(6):894-901. PubMed ID: 8100352
[TBL] [Abstract][Full Text] [Related]
48. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake.
Kölby L; Bernhardt P; Ahlman H; Wängberg B; Johanson V; Wigander A; Forssell-Aronsson E; Karlsson S; Ahrén B; Stenman G; Nilsson O
Am J Pathol; 2001 Feb; 158(2):745-55. PubMed ID: 11159212
[TBL] [Abstract][Full Text] [Related]
49. Disseminated neuroblastoma in the nude rat. A xenograft model of human malignancy.
Martinez DA; Kahwash S; O'Dorisio MS; Lloyd TV; McGhee RB; Qualman SJ
Cancer; 1996 Jan; 77(2):409-19. PubMed ID: 8625252
[TBL] [Abstract][Full Text] [Related]
50. Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney.
Balster DA; O'Dorisio MS; Summers MA; Turman MA
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F457-65. PubMed ID: 11181407
[TBL] [Abstract][Full Text] [Related]
51. Somatostatin receptor manipulation.
Visser-Wisselaar HA; Hofland LJ; van Uffelen CJ; van Koetsveld PM; Lamberts SW
Digestion; 1996; 57 Suppl 1():7-10. PubMed ID: 8813458
[TBL] [Abstract][Full Text] [Related]
52. Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1.
Engel JB; Schally AV; Halmos G; Baker B; Nagy A; Keller G
Cancer; 2005 Sep; 104(6):1312-21. PubMed ID: 16047355
[TBL] [Abstract][Full Text] [Related]
53. Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
Szepeshazi K; Schally AV; Halmos G; Sun B; Hebert F; Csernus B; Nagy A
Clin Cancer Res; 2001 Sep; 7(9):2854-61. PubMed ID: 11555603
[TBL] [Abstract][Full Text] [Related]
54. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
[TBL] [Abstract][Full Text] [Related]
55. Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas.
Cervia D; Martini D; Ristori C; Catalani E; Timperio AM; Bagnoli P; Casini G
J Neurochem; 2008 Sep; 106(5):2224-35. PubMed ID: 18624922
[TBL] [Abstract][Full Text] [Related]
56. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors.
Reubi JC; Eisenwiener KP; Rink H; Waser B; Mäcke HR
Eur J Pharmacol; 2002 Dec; 456(1-3):45-9. PubMed ID: 12450568
[TBL] [Abstract][Full Text] [Related]
57. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.
Schreff M; Schulz S; Händel M; Keilhoff G; Braun H; Pereira G; Klutzny M; Schmidt H; Wolf G; Höllt V
J Neurosci; 2000 May; 20(10):3785-97. PubMed ID: 10804219
[TBL] [Abstract][Full Text] [Related]
58. Highly efficient in vivo agonist-induced internalization of sst2 receptors in somatostatin target tissues.
Waser B; Tamma ML; Cescato R; Maecke HR; Reubi JC
J Nucl Med; 2009 Jun; 50(6):936-41. PubMed ID: 19443580
[TBL] [Abstract][Full Text] [Related]
59. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
60. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
